Opexa Presents Tovaxin Research at Federation of Clinical Immunology Societies Annual Meeting
...ine. The induction ofanti-idiotypic cytotoxic CD8+ effector T-cells and anti-ergotypicCD4+CD25+FoxP3 positive Tregs is believed to provide atherapeutically effective dual mechanism of protection to patientstreated with Tovaxin(TM). The observed regulatory immune responseshave been shown to collectively correl...MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
...uction approached 100percent even at low ratios of effector T cells to target cells. Inanimal models, the BiTE compound redirected unstimulated human Tcells to inhibit outgrowth of transplanted human tumor cells.Time-lapsed videomicroscopy showed that bscEphA2xCD3 triggered Tcells to destruct tumor cells over......ine. The induction ofanti-idiotypic cytotoxic CD8+ effector T-cells and anti-ergotypicCD4+CD25+FoxP3 positive Tregs is believed to provide atherapeutically effective dual mechanism of protection to patientstreated with Tovaxin(TM). The observed regulatory immune responseshave been shown to collectively correl...